Asthma-Related Deaths Linked to Advair and Serevent
Last Updated on May 1, 2020
Attorneys working with ClassAction.org are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.
At A Glance
- This Alert Affects
- Patients who had to be hospitalized while taking Serevent or Advair, or within 30 days of discontinuing its use. Also, families of Serevent or Advair patients who have died while taking the asthma medication or within 30 days of discontinuing use of the drug.
- Advair and Serevent have been linked to major hospitalization or death following an asthma attack.
- Additional Details
- Advair and Serevent is used in children and adults with asthma. These drugs aim to limit the number of asthma attacks experienced by the user.
- In 2006, Advair and Serevent received a black box warning outlining its potentially deadly side effects.
Advair and Serevent have been prescribed for children and adults living with asthma. These drugs are used in the long term prevention of asthma and have proven to minimize the amount of asthma attacks. Unfortunately, Advair and Serevent increase the intensity of asthma attacks that do occur. Many users of these asthma drugs have died or required hospitalization after experiencing a severe asthma attack. These asthma-related deaths have been linked to the ingredient salmeterol, which is found in both drugs.
In 2006, Advair and Serevent received a black box warning, which indicates the drug may have life-threatening side effects. Then, in 2007, the FDA advised GlaxoSmithKline to include new warnings specifically outlining the risk of side effects in children. The warning also stated that asthma attacks in Advair and Servent users may require hospitalization. If you or a loved one has experienced negative side effects while using Advair and Serevant, you may be entitled to compensation for your damages.
Before commenting, please review our comment policy.